Search

everythinglearnresearchcommunity

for

Search:↓

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Applying a specific inhibitor lightens skin and hair color.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.